Alan Aderem named director of Seattle BioMed

Tuesday, March 22, 2011 11:54 AM

Alan Aderem, an immunologist who co-founded the Institute for Systems Biology, is leaving the Seattle research center to become director of the Seattle Biomedical Research Institute.

Aderem is joining Seattle BioMed as director and taking more than 40 people from the Institute for Systems Biology with him to conduct research into new vaccines and drugs for global health.  Aderem will become president of Seattle BioMed in January 2012, replacing founder and president Ken Stuart. Stuart will remain on the Seattle BioMed faculty and on the board of trustees.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs